REFERENCES

References
  1. El Hamdaoui, Y., Zheng, F., Fritz, N. et al. Analysis of hyperforin (St. John’s wort) action at TRPC6 channel leads to the development of a new class of antidepressant drugs. Mol Psychiatry 27, 5070–5085 (2022). https://doi.org/10.1038/s41380-022-01804-3
  2. Borsini, A., Zunszain, P. A., Thuret, S., and Pariante, C. M. (2015). The role of inflammatory cytokines as key modulators of neurogenesis. Trends Neurosci. 38, 145–157. doi: 10.1016/j.tins.2014.12.006
  3. Friedli, M.J.; Inestrosa, N.C. Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer’s Disease. Molecules 2021, 26, 6531. https://doi.org/10.3390/molecules26216531
  4. Alfredo Vannacci; Effects of 12-Week Bacopa monnieri Consumption on Attention, Cognitive Processing, Working Memory, and Functions of Both Cholinergic and Monoaminergic Systems in Healthy Elderly Volunteers; https://doi.org/10.1155/2012/606424
  5. Amenta F., Tayebati S.K., Vitali D., Di Tullio M.A. Association with the cholinergic precursor choline alphoscerate and the cholinesterase inhibitor rivastigmine: An approach for enhancing cholinergic neurotransmission. Mech. Ageing Dev. 2006;127:173–179. doi: 10.1016/j.mad.2005.09.017.
  6. Lee S.H., Choi B.Y., Kim J.H., Kho A., Sohn M., Song H.K., Choi H.C., Suh S.W. Late treatment with choline alfoscerate (l-alpha glycerylphosphorylcholine, α-GPC) increases hippocampal neurogenesis and provides protection against seizure-induced neuronal death and cognitive impairment. Brain Res. 2017;1654:66–76. doi: 10.1016/j.brainres.2016.10.011.
  7. Parnetti L., Abate G., Bartorelli L., Cucinotta D., Cuzzupoli M., Maggioni M., Villardita C., Senin U. Multicentre Study of l-??-Glyceryl-Phosphorylcholine vs ST200 among Patients with Probable Senile Dementia of Alzheimer??s Type. Drugs Aging. 1993;3:159–164. doi: 10.2165/00002512-199303020-00006.
  8. Moreno M.D.J.M. Cognitive improvement in mild to moderate Alzheimer’s dementia after treatment with the acetylcholine precursor choline alfoscerate: A multicenter, double-blind, randomized, placebo-controlled trial. Clin. Ther. 2003;25:178–193. doi: 10.1016/S0149-2918(03)90023-3.
  9. Parnetti L., Mignini F., Tomassoni D., Traini E., Amenta F. Cholinergic precursors in the treatment of cognitive impairment of vascular origin: Ineffective approaches or need for re-evaluation? J. Neurol. Sci. 2007;257:264–269. doi: 10.1016/j.jns.2007.01.043.
  10. Robinson S., Sandstrom S.M., Denenberg V.H., Palmiter R.D. Distinguishing Whether Dopamine Regulates Liking, Wanting, and/or Learning About Rewards. Behav. Neurosci. 2005;119:5–15. doi: 10.1037/0735-7044.119.1.

Contact phone number: +1 (720) 807-2142

contact@shopqcharge.com

Legal Notice
Privacy Policy
Refunds
References

Copyright © 2023
Unauthorized duplication or publication of any materials from this site is expressly prohibited.